A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)
Sponsor: Aura Biosciences Inc.
Phase:
Disease: Early choroidal melanoma, Indeterminate choroidal lesions, Small choroidal melanoma
EU trial number: 2025-524405-33-00
Population: Approximately 100 adults completing the AU-011-301 Phase 3 trial for early choroidal melanoma, including indeterminate lesions and small choroidal melanomas, who previously received bel-sar or sham treatment and provide consent for long-term follow-up.
Register Investigator Interest
Interested in offering this trial to suitable patients?